Chevy Chase Trust Holdings Inc. increased its holdings in shares of Waters Corporation (NYSE:WAT) by 1.0% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 69,620 shares of the medical instruments supplier’s stock after purchasing an additional 667 shares during the period. Chevy Chase Trust Holdings Inc. owned 0.09% of Waters worth $12,498,000 as of its most recent SEC filing.
Other large investors have also modified their holdings of the company. Oppenheimer Asset Management Inc. lifted its stake in shares of Waters by 0.4% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 573 shares of the medical instruments supplier’s stock worth $105,000 after acquiring an additional 2 shares during the period. ETF Managers Group LLC acquired a new stake in shares of Waters in the 2nd quarter worth $106,000. Intellectus Partners LLC lifted its stake in shares of Waters by 4.9% in the 2nd quarter. Intellectus Partners LLC now owns 667 shares of the medical instruments supplier’s stock worth $123,000 after acquiring an additional 31 shares during the period. Edmond DE Rothschild Holding S.A. acquired a new stake in shares of Waters in the second quarter valued at about $160,000. Finally, Acrospire Investment Management LLC lifted its stake in shares of Waters by 117.4% in the second quarter. Acrospire Investment Management LLC now owns 926 shares of the medical instruments supplier’s stock valued at $170,000 after purchasing an additional 500 shares during the period. Hedge funds and other institutional investors own 92.29% of the company’s stock.
Waters Corporation (NYSE WAT) traded down $0.26 during trading hours on Wednesday, reaching $197.50. 429,800 shares of the company’s stock traded hands, compared to its average volume of 513,713. The company has a debt-to-equity ratio of 0.66, a current ratio of 6.16 and a quick ratio of 5.71. Waters Corporation has a 52-week low of $133.71 and a 52-week high of $201.95. The stock has a market cap of $15,728.45, a P/E ratio of 27.47, a P/E/G ratio of 2.87 and a beta of 0.82.
Waters (NYSE:WAT) last posted its earnings results on Tuesday, October 24th. The medical instruments supplier reported $1.77 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.74 by $0.03. Waters had a net margin of 24.34% and a return on equity of 23.61%. The firm had revenue of $565.58 million during the quarter, compared to the consensus estimate of $555.25 million. During the same period last year, the firm posted $1.57 EPS. The firm’s revenue for the quarter was up 7.4% on a year-over-year basis. sell-side analysts predict that Waters Corporation will post 7.42 EPS for the current year.
In other news, Director William J. Miller sold 3,500 shares of Waters stock in a transaction dated Tuesday, December 5th. The shares were sold at an average price of $194.94, for a total transaction of $682,290.00. Following the completion of the sale, the director now directly owns 25,849 shares in the company, valued at $5,039,004.06. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP Elizabeth B. Rae sold 12,000 shares of Waters stock in a transaction dated Friday, November 3rd. The stock was sold at an average price of $197.95, for a total transaction of $2,375,400.00. Following the sale, the senior vice president now owns 18,129 shares of the company’s stock, valued at $3,588,635.55. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 45,913 shares of company stock valued at $9,084,685. Insiders own 5.07% of the company’s stock.
Several analysts recently commented on WAT shares. Zacks Investment Research upgraded shares of Waters from a “hold” rating to a “buy” rating and set a $211.00 price objective for the company in a research note on Monday, October 23rd. Barclays raised their price objective on shares of Waters from $188.00 to $193.00 and gave the company an “equal weight” rating in a research note on Wednesday, October 25th. Morgan Stanley upgraded shares of Waters from an “underweight” rating to an “equal weight” rating and set a $192.00 price objective for the company in a research note on Monday, December 4th. Deutsche Bank raised their price objective on shares of Waters from $199.00 to $200.00 and gave the company a “hold” rating in a research note on Wednesday, October 25th. Finally, Cowen reiterated a “hold” rating and issued a $190.00 price objective on shares of Waters in a research note on Friday, November 3rd. One research analyst has rated the stock with a sell rating, ten have given a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. Waters presently has a consensus rating of “Hold” and an average price target of $193.62.
COPYRIGHT VIOLATION WARNING: “Chevy Chase Trust Holdings Inc. Acquires 667 Shares of Waters Corporation (WAT)” was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this article on another publication, it was copied illegally and republished in violation of international trademark and copyright law. The original version of this article can be read at https://www.dispatchtribunal.com/2017/12/13/chevy-chase-trust-holdings-inc-acquires-667-shares-of-waters-corporation-wat.html.
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.